↓ Skip to main content

Intravenous enalaprilat for treatment of acute hypertensive heart failure in the emergency department

Overview of attention for article published in International Journal of Emergency Medicine, December 2016
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)

Mentioned by

twitter
5 X users
facebook
1 Facebook page

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
32 Mendeley
Title
Intravenous enalaprilat for treatment of acute hypertensive heart failure in the emergency department
Published in
International Journal of Emergency Medicine, December 2016
DOI 10.1186/s12245-016-0125-4
Pubmed ID
Authors

Syed Imran Ayaz, Craig M. Sharkey, Gregory M. Kwiatkowski, Suprat Saely Wilson, Reba S. John, Rosa Tolomello, Arushi Mahajan, Scott Millis, Phillip D. Levy

Abstract

Afterload reduction with bolus enalaprilat is used by some for management of acute hypertensive heart failure (HF) but existing data on the safety and effectiveness of this practice are limited. The purpose of this study was to evaluate the clinical effects of bolus enalaprilat when administered to patients with acute hypertensive heart failure. We performed an IRB-approved retrospective cohort study of patients who presented to the emergency department of a large urban academic hospital. Patients were identified by pharmacy record and included if they received enalaprilat intravenous (IV) bolus in the setting of acute hypertensive HF. A total of 103 patients were included. Patients were hypertensive on presentation (systolic blood pressure [SBP] = 195.2 [SD ± 32.3] mmHg) with significantly elevated mean NT-proBNP levels (3797.8 [SD ± 6523.2] pg/ml). The mean dose of enalaprilat was 1.3 [SD ± 0.7] mg, with most patients (76.7%) receiving a single 1.25 mg bolus. By 3 h post-enalaprilat, SBP had decreased substantially (-30.5 mmHg) with only 2 patients (1.9%) developing hypotension. Renal function was unaffected, with no significant change in serum creatinine by 72 h. In the 30 days post-admission, patients spent an average of 23 [SD ± 7.5] days alive and out of hospital. In this retrospective cohort of acute hypertensive HF patients, bolus IV enalaprilat resulted in a substantial reduction in systolic BP without adverse effect.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 13%
Other 3 9%
Student > Bachelor 3 9%
Professor 2 6%
Student > Doctoral Student 2 6%
Other 4 13%
Unknown 14 44%
Readers by discipline Count As %
Medicine and Dentistry 14 44%
Unspecified 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Agricultural and Biological Sciences 1 3%
Other 1 3%
Unknown 13 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 January 2017.
All research outputs
#8,232,313
of 25,365,817 outputs
Outputs from International Journal of Emergency Medicine
#280
of 649 outputs
Outputs of similar age
#141,730
of 434,276 outputs
Outputs of similar age from International Journal of Emergency Medicine
#7
of 8 outputs
Altmetric has tracked 25,365,817 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 649 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,276 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one.